SCHEMBL8487663

SCHEMBL8487663

CC(=O)C(Cc1c[nH]c2ccccc12)(NCc1ccccc1)OC(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.47
CCKBR P32239 2/20 0.47
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
SLC6A2 P23975 1/20 0.44
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
TSHR P16473 2/20 0.43
CYP1A2 P05177 1/20 0.43
PKM P14618 1/20 0.43
CYP2C19 P33261 1/20 0.43
BLM P54132 1/20 0.43
KDM4E B2RXH2 2/20 0.42
TACR1 P25103 1/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8632695 0.77 LMNA (0.48) MC4RLMNASLC6A2FNTAFNTB
SCHEMBL9373817 0.74 KMT2A (0.54) MC4RLMNAKMT2AMEN1MAPT
SCHEMBL8999053 0.74 CCKBR (0.53) MC4RCCKBRLMNASMN1; SMN2SLC6A2
SCHEMBL8999327 0.74 CCKBR (0.51) MC4RCCKBRLMNASMN1; SMN2SLC6A2
SCHEMBL27785465 0.74 CCKBR (0.52) CCKBRLMNASMN1; SMN2KMT2AMEN1
SCHEMBL8486077 0.74 CCKBR (0.61) CCKBRLMNAKMT2AMEN1TSHR
SCHEMBL27336638 0.73 KMT2A (0.54) MC4RKMT2A
SCHEMBL9613706 0.73 CCKBR (0.56) MC4RCCKBRLMNASMN1; SMN2SLC6A2
SCHEMBL4121788 0.72 PKM (0.50) LMNASMN1; SMN2KMT2AMEN1TSHR
SCHEMBL4132288 0.72 PKM (0.50) LMNASMN1; SMN2KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5856354-A RESPIRATORY SYSTEM DISORDERS, ANTIINFLAMMATORY AGENTS, GASTROINTESTINAL DISORDERS, VISION DEFECTS, ANTIALLERGENS,PAIN, NERVOUS SYSTEM DISORDERS, HEADACHES WARNER-LAMBERT COMPANY (US) 1999-01-05 US disclosed